935685-88-4

Usage

Uses

Used in Organic Synthesis:
3-Cyano-5-fluorobenzeneboronic acid pinacol ester, 96% is used as a versatile building block for the synthesis of various organic molecules. Its unique structure allows for the creation of a wide range of compounds, making it a valuable tool in the development of new organic materials.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 3-Cyano-5-fluorobenzeneboronic acid pinacol ester, 96% is used as a key intermediate in the synthesis of various pharmaceuticals. Its high purity and reactivity make it an ideal candidate for the development of new drugs and therapeutic agents.
Used in Agrochemical Development:
3-Cyano-5-fluorobenzeneboronic acid pinacol ester, 96% is also utilized in the agrochemical industry for the synthesis of various agrochemicals. Its ability to form a wide range of compounds makes it a valuable resource for the development of new pesticides, herbicides, and other agricultural chemicals.
Used in Laboratory and Industrial Settings:
Due to its high purity and effectiveness, 3-Cyano-5-fluorobenzeneboronic acid pinacol ester, 96% is a reliable reagent for use in both laboratory and industrial settings. Its versatility and reactivity make it suitable for a wide range of applications, from research and development to large-scale production processes.

Upstream product

• 73183-34-3 bis(pinacol)diborane 
• 179898-34-1 3-bromo-5-fluorobenzonitrile 

Downstream Products

• 935685-90-8 STX-107 
• 1318763-80-2 ethyl 1-benzyl-4-(3'-cyano-5'-fluoro-[1,1'-biphenyl]-4-yl)-2-methyl-1H-pyrrole-3-carboxylate 
• 1343978-35-7 2-amino-4-(3'-cyano-5'-fluoro-[1,1'-biphenyl]-3-yl)-4H-benzo[h]chromene-3-carbonitrile 
• 1231208-88-0 3-{2-(3-Chloro-4-fluorophenyl)-5-[(4-oxoimidazolidin-1-yl)carbonyl]furan-3-yl}-5-fluorobenzenecarbonitrile 
• 1231209-20-3 C₁₈H₈ClF₂NO₃ 
• 1231209-02-1 Ethyl 5-(3-chloro-4-fluorophenyl)-4-(3-cyano-5-fluorophenyl)furan-2-carboxylate 
• 1266520-50-6 4-(3-cyano-4-fluorophenyl)-5-(3-cyano-5-fluorophenyl)-1,3-thiazole-2-carboxylic acid 
• 1266520-65-3 4-(3-chlorophenyl)-5-(3-cyano-5-fluorophenyl)-1,3-thiazole-2-carboxylic acid 
• 1266519-73-6 5-{5-(3-cyano-5-fluorophenyl)-2-[(4-oxoimidazolidin-1-yl)carbonyl]-1,3-thiazole-4-yl}-2-fluorobenzenecarbonitrile 
• 1266519-86-1 3-{4-(3-chlorophenyl)-2-[(4-oxoimidazolidin-1-yl)carbonyl]-1,3-thiazole-5-yl}-5-fluorobenzenecarbonitrile 
• 1245510-54-6 C₂₅H₂₅FN₄O₂ 
• 1245509-34-5 C₂₄H₂₅FN₄O₂ 

Relevant academic research and scientific papers

1,3-THIAZOL-2-YL SUBSTITUTED BENZAMIDES

The present invention relates to 1,3-thiazol-2-yl substituted benzamide compounds of general formula (I) as described and defined herein, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of neurogenic disorder, as a sole agent or in combination with other active ingredients.

INDOLIZINE DERIVATIVES AS PHOSHOINOSITIDE 3-KINASES INHIBITORS

Compounds of formula (I), defined herein, inhibit phosphoinositide 3-kinases (PI3K) and are useful for the treatment of disorders associated with PI3K enzymes.

SUBSTITUTED (THIAZOLYL-CARBONYL)IMIDAZOLIDINONES AND USE THEREOF

The present invention relates to novel substituted furancarboxamides, methods for their production, their use for the treatment and/or prevention of diseases, as well as their use for the production of medicaments for the treatment and/or prophylaxis of diseases, especially retroviral diseases, in humans and/or animals.

SUBSTITUTED (THIOPHENYL-CARBONYL)IMIDAZOLIDINONES, AND USE THEREOF

The present invention relates to novel substituted (thiophenyl-carbonyl)imidazolidinones, methods for their production, their use for the treatment and/or prevention of diseases, as well as their use for the production of medicaments for the treatment and/or prophylaxis of diseases, especially retroviral diseases, in humans and/or animals.

SUBSTITUTED FURANCARBOXAMIDES, AND USE THEREOF

The present invention relates to novel substituted furancarboxamides, methods for their production, their use for the treatment and/or prevention of diseases, as well as their use for the production of medicaments for the treatment and/or prophylaxis of diseases, especially retroviral diseases, in humans and/or animals.

BIARYL OXYACETIC ACID COMPOUNDS

The present invention provides biaryl oxyacetic acid compounds which may be useful for treating inflammatory disorders, including disorders affecting the respiratory system and skin. The compounds provided include those of the general formula I.

Thiazolyl mglur5 antagonists and methods for their use

The identification of a unique series of compounds which possesses special advantages in terms of drug-like properties due to their possessing advantageous properties in terms of potency and/or pharmacokinetic and/or selectivity and/or in vivo receptor occupancy properties. Specifically, the selection of a 1,3-thiazol-2-yl ring member linked by an ethynylene to the 3 position of a pyridyl ring or the 5 position of a pyrimidinyl ring, wherein the ring is substituted with selected substituents, results in a compound having superior drug-like properties. The invention includes pharmaceutically acceptable salt forms of these heterocyclic compounds, in particular chloride salts and trifluoroacetate salts.